Current Neuro-Oncology

Volume 25 Number 22
30 November 2023

Home > Publications > Current Neuro-Oncology > Volume 25, Year 2023 > Number 22, 30 november

Zhu Q, Jiang H, Cui Y, Ren X, Li M, Zhang X, Li H, Shen S, Li M, Lin S.
Intratumoral calcification: not only a diagnostic but also a prognostic indicator in oligodendrogliomas.
Eur Radiol. 2023 Nov 16. doi: 10.1007/s00330-023-10405-9. PMID: 37968476. Observational study˰

Inoue T, Endo T, Muto J, Umebayashi D, Mitsuhara T, Shigekawa S, Kanematsu R, Iwasaki M, Takami T, Hida K, Mizuno M; Investigators of Intramedullary Spinal Cord Tumors in the Neurospinal Society of Japan.
Shorter survival time of adolescents and young adult patients than older adults with spinal cord glioblastoma: a multicenter study.
J Neurosurg Spine. 2023 Nov 17:1-10. doi: 10.3171/2023.9.SPINE23642. PMID: 37976504. Observational study˰

Haas-Kogan DA, Aboian MS, Minturn JE, Leary SES, Abdelbaki MS, Goldman S, Elster JD, Kraya A, Lueder MR, Ramakrishnan D, von Reppert M, Liu KX, Rokita JL, Resnick AC, Solomon DA, Phillips JJ, Prados M, Molinaro AM, Waszak SM, Mueller S.
Everolimus for Children With Recurrent or Progressive Low-Grade Glioma: Results From the Phase II PNOC001 Trial.
J Clin Oncol. 2023 Nov 17:JCO2301838. doi: 10.1200/JCO.23.01838. PMID: 37978951. Interventional study.

Kilburn LB, Khuong-Quang DA, Hansford JR, Landi D, van der Lugt J, Leary SES, Driever PH, Bailey S, Perreault S, McCowage G, Waanders AJ, Ziegler DS, Witt O, Baxter PA, Kang HJ, Hassall TE, Han JW, Hargrave D, Franson AT, Yalon Oren M, Toledano H, Larouche V, Kline C, Abdelbaki MS, Jabado N, Gottardo NG, Gerber NU, Whipple NS, Segal D, Chi SN, Oren L, Tan EEK, Mueller S, Cornelio I, McLeod L, Zhao X, Walter A, Da Costa D, Manley P, Blackman SC, Packer RJ, Nysom K.
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nat Med. 2023 Nov 17. doi: 10.1038/s41591-023-02668-y. PMID: 37978284. Interventional study.

Gregucci F, Di Guglielmo FC, Surgo A, Carbonara R, Laera L, Ciliberti MP, Gentile MA, Calbi R, Caliandro M, Sasso N, Davi' V, Bonaparte I, Fanelli V, Giraldi D, Tortora R, Internò V, Giuliani F, Surico G, Signorelli F, Lombardi G, Fiorentino A.
Reirradiation with radiosurgery or stereotactic fractionated radiotherapy in association with regorafenib in recurrent glioblastoma.
Strahlenther Onkol. 2023 Nov 21. doi: 10.1007/s00066-023-02172-9. PMID: 37987802. Observational study˰

Zhang H, Jiang X, Ren F, Gu Q, Yao J, Wang X, Zou S, Gan Y, Gu J, Xu Y, Wang Z, Liu S, Wang X, Wei B.
Development and external validation of dual online tools for prognostic assessment in elderly patients with high-grade glioma: a comprehensive study using SEER and Chinese cohorts.
Front Endocrinol (Lausanne). 2023 Nov 21;14:1307256. doi: 10.3389/fendo.2023.1307256. PMID: 38075045. Observational study.

Zhong S, Fu X, Wu C, Liu R, Li S.
Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?
Neurosurg Rev. 2023 Nov 23;46(1):311. doi: 10.1007/s10143-023-02209-8. PMID: 37993665. Observational study.


Mikobi EK, Voorhees G, Mahmood A, Gandhi A, Bailey M, Phillips J.
Influence of Tumor-Treating Fields in a Young Patient With Primary Spinal Glioblastoma Multiforme (GBM): A Case Report of a Rare Tumor.
Cureus. 2023 Nov 26;15(11):e49441. doi: 10.7759/cureus.49441. PMID: 38149153. Case report.

Kassotis AS, Garcia MDL, Sun Y, Mbekeani JN, Kazim M.
Clinically Aggressive Low-Grade Optic Nerve Glioma in an Adult Treated With Selumetinib.
J Neuroophthalmol. 2023 Nov 27. doi: 10.1097/WNO.0000000000002023. PMID: 38015651. Case report˰

Kleinberg L, Ye X, Supko J, Stevens GHJ, Shu HK, Mikkelsen T, Lieberman F, Lesser GJ, Lee E, Grossman SA.
A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).
J Neurooncol. 2023 Nov 28. doi: 10.1007/s11060-023-04514-0. PMID: 38015376. Interventional study˰

Sienna J, Kahalley LS, Mabbott D, Grosshans D, Santiago AT, Paulino ADC, Merchant TE, Manzar GS, Dama H, Hodgson DC, Chintagumpala M, Okcu MF, Whitehead WE, Laperriere N, Ramaswamy V, Bartels U, Tabori U, Bennett JM, Das A, Craig T, Tsang DS.
Proton Therapy Mediates Dose Reductions to Brain Structures Associated with Cognition in Children with Medulloblastoma.
Int J Radiat Oncol Biol Phys. 2023 Nov 29:S0360-3016(23)08164-6. doi: 10.1016/j.ijrobp.2023.11.035. PMID: 38040059. Observational study˰

Ahn WK, Hahn SM, Yoon HI, Lee J, Park EK, Shim KW, Kim DS, Suh CO, Kim SH, Lyu CJ, Han JW.
Long-term Outcomes of Protocol-based Treatment for Newly Diagnosed Medulloblastoma.
Cancer Res Treat. 2023 Nov 30. doi: 10.4143/crt.2023.865. PMID: 38037318. Observational study.


Baumgarten P, Prange G, Kamp MA, Monden D, Neef V, Schwarzer F, Dubinski D, Dinc N, Weber KJ, Czabanka M, Hattingen E, Ronellenfitsch MW, Steinbach JP, Senft C.
Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat.
J Neurooncol. 2023 Nov 30. doi: 10.1007/s11060-023-04518-w. PMID: 38032426. Observational study.